Baird analyst Joe Vruwink lowered the firm’s price target on Phreesia (PHR) to $30 from $34 and keeps an Outperform rating on the shares. The firm said they delivered inline revenue growth as step change in profitability continues to take center stage, with outlook for FY25 (Jan) EBITDA again moving higher; revenue was narrowed and in-line with estimates.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHR:
- Phreesia’s Global Expansion: Navigating Legal Hurdles and Compliance Costs
- Phreesia Reports Strong Q3 2025 Performance
- Phreesia jumps 6% to $22.83 after Q3 results, updated guidance
- Phreesia narrows FY25 revenue view to $418M-$420M, consensus $419.1M
- Phreesia guides initial FY26 revenue $472M-$482M, consensus $480.5M